Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Preprint in English | medRxiv | ID: ppmedrxiv-21262186

ABSTRACT

Recent studies have shown a temporal increase in the neutralizing antibody potency and breadth to SARS-CoV-2 variants in coronavirus disease 2019 (COVID-19) convalescent individuals. Here, we examined longitudinal antibody responses and viral neutralizing capacity to the B.1 lineage virus (Wuhan related), to variants of concern (VOCs: Alpha, Beta, Gamma, and Delta) and a local variant of interest (VOI: Lambda) in volunteers receiving the Sputnik V vaccine in Argentina. A collection of 472 serum samples obtained between January and September 2021 was used. The analysis indicates that while anti-spike IgG levels significantly wane over time, the neutralizing capacity to the first-wave linages of SARS-CoV-2 and VOC are maintained within four months of vaccination. In addition, an improved antibody cross-neutralizing ability to circulating variants of concern (Beta, Gamma and Delta) was observed over time of vaccination. The viral variants that displayed higher escape to neutralizing antibodies with respect to the original virus (Beta and Gamma variants) were the ones showing the largest increase in susceptibility to neutralization over time after vaccination. Our observations indicate that serum neutralizing antibodies are maintained for at least four month and show a reduction of VOC escape over time of vaccination.

2.
Carolina Torres; Laura Mojsiejczuk; Dolores Acuna; Sofia Alexay; Ariel Amadio; Paula Aulicino; Humberto Debat; Franco Fernandez; Stephanie Goya; Guido Konig; Mercedes Nabaes Jodar; Luis Pianciola; Sofia Bengoa; Marco Cacciahue; Cecilia Camussone; Maria Jose Dus Santos; Maria Florencia Eberhardt; Ailen Fernandez; Maria Ines Gismondi; Matias Irazoqui; Silvina Lusso; Nathalie Marquez; Marianne Munoz; Monica Natale; Belen Pisano; Andrea Puebla; Viviana Re; Ezequiel Sosa; Jonathan Zaiat; Sebastian Zunino; Dario Do porto; Maria Elina Acevedo; Cristina Alvarez Lopez; Maria Laura Alvarez; Patricia Angeleri; Andres Angelletti; Manuel Arca; Gabriela Barbas; Ana Bertone; Agustina Bonnet; Ignacio Bourlot; Alejandro Castello; Gonzalo Castro; Carolina Ceriani; Carlos Cimino; Julian Cipelli; Maria Colmeiro; Andres Cordero; Carolina Cristina; Sofia Di Bella; Regina Ercole; Yesica Espasandin; Carlos Espul; Andrea Falaschi; Facundo Fernandez Moll; Andrea Gatelli; Sandra Goni; Maria E Jofre; Jose Jaramillo; Natalia Labarta; Maria A Lacaze; Rocio Larreche; Viviana Leiva; Gustavo Levin; Erica Luczak; Marcelo Mandile; Carla Massone; Melina Mazzeo; Carla Medina; Belen Monaco; Luciana Montoto; Viviana Mugna; Alejandra Musto; Guillermo Ojeda; Carolina Pintos; Marcia Pozzati; Marilina Rahhal; Claudia Rechimont; Federico Remes Lenicov; Gabriela Rompato; Vanesa Seery; Leticia Siri; Julieta Spina; Cintia Streitenberger; Ariel Suarez; Jorgelina Suarez; Paula Sujanski; Juan M Talia; Clara Theaux; Guillermo Thomas; Marina Ticeira; Estefania Tittarelli; Rosana Toro; Osvaldo Uez; Maria B Zaffanella; Cecilia Ziehm; Martin Zubieta; - PAIS Consortium; Alicia Mistchenko; Laura Valinotto; Mariana Viegas.
Preprint in English | medRxiv | ID: ppmedrxiv-21260779

ABSTRACT

Molecular surveillance of SARS-CoV-2 variants was performed on a total of 2,406 samples from the capital city and nine provinces of Argentina, during 30 epidemiological weeks (EW) that covered the end of the first wave and the beginning of the ongoing second wave of the COVID-19 pandemic in the country (EW 44/2020 to EW 20/2021). The surveillance strategy was mainly based on Sanger sequencing of a Spike coding region that allows the simultaneous identification of signature mutations associated with worldwide circulating variants. In addition, whole SARS-CoV-2 genome sequences were obtained from 456 samples. The main variants found were Gamma, Lambda and Alpha, and to a lesser extent, Zeta and Epsilon. Whereas Gamma dominated in different regions of the country, both Gamma and Lambda prevailed in the most populated area, the metropolitan region of Buenos Aires (MABA), although showing a heterogeneous distribution along this region. This cost-effective surveillance protocol allowed for a rapid response in a limited access to resources scenario, added information on the expansion of the Lambda variant in South America and contributed to the implementation of public health measures to control the disease spread in Argentina.

SELECTION OF CITATIONS
SEARCH DETAIL
...